News + Filings Transactions
|
HASTINGS PAUL J
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 1.8k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 12.9k | $38.74 | $500.7k | | 06/14/2023 |
| 06/05/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 580 | $38.34 | $22.2k | | 06/05/2023 |
| 09/29/2022 | Nkarta, Inc. | NKTX | Sale | Common Stock | 498 | $13.00 | $6.5k | | 09/28/2022 |
| 09/28/2022 | Nkarta, Inc. | NKTX | Sale | Common Stock | 23.4k | $13.03 | $304.6k | | 09/28/2022 |
| 09/21/2022 | Nkarta, Inc. | NKTX | Sale | Common Stock | 6.1k | $13.01 | $79.7k | | 09/21/2022 |
| 06/17/2022 | Nkarta, Inc. | NKTX | Grant | Stock Option (right to buy) | 120k | $12.25 | $1.5M | | 06/17/2022 |
| 06/17/2022 | Nkarta, Inc. | NKTX | Grant | Common Stock | 19.5k | $0.00 | $0 | | 06/17/2022 |
| 06/08/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 1.2k | $0.00 | $0 | | 06/08/2022 |
| 06/08/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 8.2k | $59.39 | $488.5k | | 06/08/2022 |
| 01/14/2022 | Nkarta, Inc. | NKTX | Grant | Common Stock | 41.9k | $0.00 | $0 | | 01/14/2022 |
| 01/14/2022 | Nkarta, Inc. | NKTX | Grant | Stock Option (right to buy) | 251.1k | $12.14 | $3M | | 01/14/2022 |
| 09/29/2021 | Nkarta, Inc. | NKTX | Sale | Common Stock | 8.3k | $27.20 | $225.1k | | 09/29/2021 |
| 09/29/2021 | Nkarta, Inc. | NKTX | Sale | Common Stock | 223 | $26.53 | $5.9k | | 09/29/2021 |
| 06/21/2021 | Nkarta, Inc. | NKTX | Sale | Common Stock | 4.7k | $26.39 | $123.8k | | 06/21/2021 |
| 06/21/2021 | Nkarta, Inc. | NKTX | Sale | Common Stock | 3.8k | $26.89 | $102.4k | | 06/21/2021 |
| 06/09/2021 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 7.6k | $60.96 | $464.9k | | 06/09/2021 |
| 06/09/2021 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 1.1k | $0.00 | $0 | | 06/09/2021 |
| 06/04/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 630 | $62.19 | $39.2k | | 06/04/2021 |
| 03/30/2021 | Nkarta, Inc. | NKTX | Sale | Common Stock | 11.5k | $30.23 | $346.5k | | 03/30/2021 |
| 03/30/2021 | Nkarta, Inc. | NKTX | Sale | Common Stock | 2.4k | $31.24 | $75.3k | | 03/30/2021 |
| 03/30/2021 | Nkarta, Inc. | NKTX | Sale | Common Stock | 3.1k | $32.21 | $100.8k | | 03/30/2021 |
| 01/08/2021 | Nkarta, Inc. | NKTX | Grant | Stock Option (right to buy) | 157.5k | $54.89 | $8.6M | | 01/08/2021 |
| 07/09/2020 | Nkarta, Inc. | NKTX | Grant | Stock Option (right to buy) | 202.4k | $18.00 | $3.6M | | 07/09/2020 |
| 06/09/2020 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 1.3k | $0.00 | $0 | | 06/09/2020 |
| 06/09/2020 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 8k | $47.65 | $382.5k | | 06/09/2020 |
| 06/04/2020 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 2k | $47.46 | $96.1k | | 06/04/2020 |
| 06/05/2019 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 4.1k | $0.00 | $0 | | 06/04/2019 |
| 06/05/2019 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 8.4k | $43.54 | $367.3k | | 06/04/2019 |
| 06/04/2019 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 782 | $42.66 | $33.4k | | 06/04/2019 |
| 06/13/2018 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 782 | $0.00 | $0 | | 06/13/2018 |
| 06/13/2018 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 4.7k | $38.35 | $180k | | 06/13/2018 |
| 06/08/2018 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 12.7k | $2.50 | $31.8k | | 06/08/2018 |
| 06/04/2018 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 771 | $33.90 | $26.1k | | 06/04/2018 |
| 10/10/2017 | OncoMed Pharmaceuticals Inc | OMED | Sale | Common Stock | 52 | $4.26 | $221.6 | | 10/10/2017 |
|
|